The diabetes clinic at HDZ NRW is a top-ranked clinic at the university hospital in Bochum in Germany. For the past two years (2020 and 2022), the clinic has received the highly regarded award "5-Sterne-Auszeichnung" awarded by the institute "Bundesverband Klinischer Diabetes- Einrichtungen " (BKvD).

The clinic will evaluate the VibroSense Meter® II and the application Diabetes Foot Screening during the fall of 2022, with a stated goal of purchasing the instrument after the evaluation is completed if it meets the set requirements.

"The evaluation at HDZ NRW confirms that we are taking an important step to establish a reference center at a very reputable diabetes clinic in Germany. We have had very promising conversations with the clinic, which confirms a consensus on the need for significantly improved follow-up and diagnostics of the diabetic foot and associated nerve damage," says Hans Wallin, CEO of VibroSense Dynamics AB.

About Diabetes Herz und Diabetes Center in NRW Bad Oeynhausen
The Heart and Diabetes Center North Rhine-Westphalia (HDZ NRW) is a university clinic at the Ruhr University in Bochum and a leading international center for the treatment of heart, circulatory and diabetes diseases. With 35,000 heart and diabetes patients per year, of which 14,500 are inpatients, HDZ NRW is one of the largest and most modern clinical centers of its kind in Europe. The diabetes clinic at HDZ NRW has around 2,000 diabetes patients with all types of diabetes and its complications who are treated at the clinic every year. In addition to the treatment of cardiovascular diseases as well as endocrinology and gastroenterology, the diabetes center specializes in the treatment of nerve damage and circulatory disorders, including the care of diabetic foot syndrome.

Contact
Hans Wallin, CEO VibroSense Dynamics AB
Tel: +46 40 88 026
Email: info@vibrosense.com
www.vibrosense.se

About VibroSense Dynamics AB (publ)
VibroSense Dynamics AB (publ) develops and sells medical technology products and services for diagnostic support for nerve damage in the hands and feet. The method involves measuring and quantifying the ability to feel vibrations at several frequencies. The company's customers are diabetes clinics, occupational health care, hospitals, health centers and researchers.

Our vision is that the company's products should be a standard instrument in all neurological examinations to detect early signs of changes in sensation so that patients and their caregivers can implement preventive measures that prevent, reduce or delay the onset of nerve damage in the hands and feet.